Greenwich LifeSciences, Inc. (GLSI) Total Assets by Year
Greenwich LifeSciences, Inc. closed fiscal year 2025 with $6.2M in total assets, $5.8M in total liabilities and $353K in shareholder equity. This represents an increase of 50.9% from the prior fiscal year. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters Greenwich LifeSciences, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
GLSI Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K |
|---|---|---|---|---|---|---|---|
| Total Assets | $6.2M+50.9% | $4.1M-41.5% | $7.0M-48.1% | $13.5M-50.5% | $27.2M-5.1% | $28.7M+107419.8% | $27K |
| Total Liabilities | $5.8M+82.9% | $3.2M+981.9% | $294K+12.0% | $263K-31.7% | $385K-63.2% | $1.0M-24.1% | $1.4M |
| Total Equity | $353K-61.1% | $909K-86.4% | $6.7M-49.3% | $13.2M-50.8% | $26.8M-2.9% | $27.6M+2146.1% | -$1.4M |
GLSI Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-K | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $8.9M+184.0% | $10.5M+281.9% | $6.2M+50.9% | $3.8M-34.6% | $3.1M-56.8% | $2.8M-50.1% | $4.1M-41.5% | $5.8M-36.3% | $7.2M-34.0% | $5.5M-53.8% | $7.0M-48.1% | $9.1M-41.5% |
| Total Liabilities | $5.8M+128.5% | $5.2M+105.3% | $5.8M+82.9% | $2.0M+139.4% | $2.5M+86.3% | $2.6M+554.6% | $3.2M+981.9% | $842K+183.4% | $1.4M+348.7% | $390K+65.4% | $294K+12.0% | $297K+25.0% |
| Total Equity | $3.1M+415.8% | $5.3M+2528.8% | $353K-61.1% | $2.2M-56.1% | $604K-89.7% | $200K-96.1% | $909K-86.4% | $5.0M-43.7% | $5.9M-44.8% | $5.1M-56.2% | $6.7M-49.3% | $8.9M-42.6% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Greenwich LifeSciences, Inc. financials
Frequently Asked Questions
What was Greenwich LifeSciences, Inc.'s total assets in fiscal year 2025?
Greenwich LifeSciences, Inc. closed fiscal year 2025 with $6.2M in total assets, $5.8M in total liabilities and $353K in shareholder equity.
How fast is Greenwich LifeSciences, Inc.'s total assets growing?
Greenwich LifeSciences, Inc. (GLSI) total assets rose by 50.9% year over year, from $4.1M to $6.2M in fiscal year 2025.
How has Greenwich LifeSciences, Inc.'s total assets changed over the years?
Across the 7 fiscal years this page covers, Greenwich LifeSciences, Inc. (GLSI) total assets went from $27K in fiscal year 2019 to $6.2M in fiscal year 2025.
What was Greenwich LifeSciences, Inc.'s total assets in the most recent quarter?
Greenwich LifeSciences, Inc. (GLSI) reported $8.9M in total assets in Q2 2026. This represents an increase of 184.0% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Greenwich LifeSciences, Inc. (GLSI) reported on that line in every period on record.